• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Israeli Startup Aidoc Raises $65m for AI-Powered Medical Imaging Platform

Share:

July 28, 2021

What You Should Know:

– Aidoc, a Tel Aviv-based provider of artificial intelligence (AI) solutions for medical imaging, announced it has raised $65M in Series C funding led by General Catalyst, bringing its total funding to $140M.

– This Series C round comes on the heels of a surge in demand for Aidoc’s AI-driven solutions, including the largest clinical deployment of AI in healthcare through its partnership with Radiology Partners.

– Founded in 2016, Aidoc’s solutions aid radiologists in reducing turnaround time and increasing quality and efficiency by flagging acute anomalies in real-time. Radiologists benefit from state-of-the-art deep learning technology that is “Always -On”, running behind the scenes and freeing them to focus on the diagnosis itself. Aidoc’s offering is one of the most comprehensive in the field, enabling diagnostic aid to a broad set of pathologies.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • ZOLL Acquires Payor LogicZOLL Acquires Payor Logic
  • DrFirst Adds Adobe Sign to Backline® Secure Care Collaboration PlatformDrFirst Adds Adobe Sign to Backline® Secure Care Collaboration Platform
  • IDbyDNA Raises $20 Million in Series B Financing to Continue Advancements in Infectious Disease Diagnosis and Pathogen IdentificationIDbyDNA Raises $20 Million in Series B Financing to Continue Advancements in Infectious Disease Diagnosis and Pathogen Identification
  • Labcorp Completes Acquisition of Personal Genome DiagnosticsLabcorp Completes Acquisition of Personal Genome Diagnostics
  • Bridge Connector Lands $25.5M to Expand Healthcare Integration PlatformBridge Connector Lands $25.5M to Expand Healthcare Integration Platform
  • Komodo Health Acquires Breakaway Partners to Improve Patient AccessKomodo Health Acquires Breakaway Partners to Improve Patient Access
  • BioNTech Completes Acquisition of Neon TherapeuticsBioNTech Completes Acquisition of Neon Therapeutics
  • How Johnson & Johnson is using startup incubators to find new talentHow Johnson & Johnson is using startup incubators to find new talent

Trending This Week

  • Immuno-Oncology Pipeline Cuts Explained
  • Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
  • USFDA Accepts Glenmark’s Application to Initiate a Human Trial of Molecules for Advanced Solid Tumors and Lymphomas
  • Concentra’s Buy Offer May Jeopardize Jounce’s Merger with Redx
  • Pfizer Acquires Seagen For $43B To Tackle Cancer
  • Janssen’s Novel Dengue Antiviral Demonstrates ‘strong Protection’ in Pre-Clinical Data

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications